Denmark's economy saw a 0.6% growth in Q2, largely driven by a resurgence in pharmaceutical output which underscores the industry's critical role in national economic fluctuations.
The dependence on the drug manufacturing sector is illustrated by the fact that it accounted for half of Denmark's economic expansion last year, showcasing its significance.
According to Palle Sorensen of Nykredit, pharmaceutical companies cause 'large fluctuations' in GDP, indicating their 'disproportionately large role' in Denmark's industrial performance.
Danish drugmakers reported an 8.5% rise in production, reversing the significant decline seen in the previous quarter, marking a robust recovery in the sector.
Collection
[
|
...
]